A cost-effective option for simple linear epitopes
Precise identification of linear epitopes of important therapeutic and diagnostic antibodies using fully overlapping linear peptides was invented at Pepscan more than 20 years ago. Pepscan has since perfected this technology and broadened its application, delivering unparalleled sensitivity and reproducibility for epitope mapping of all types of samples. Linear epitope mapping is our most budget-conscious choice, used when an epitope is suspected to be at least partly linear, for example when the antigen was a peptide itself.
Linear epitopes are defined by the amino acids in a particular region of a protein, which are nearby in the sequence as well as structure. Structural features are not important for recognition.
Case report: Linear epitope mapping for anti-CD3ɛ monoclonal antibodies
In-depth information on the specific and unique target binding site (i.e. epitope) for novel antibodies is often required for new therapeutics. Comparative epitope mapping can also provide important functional information for translating potential drugs from animal testing to human trials.
A monoclonal antibody directed against human anti-CD3ɛ was tested on a library of fully overlapping 15-mer linear peptides based on the sequences of cynomolgus monkey and human CD3ɛ. Recorded intensity profiles clearly showed that even though the sequences differed slightly, the antibody bound at the N-terminus of both CD3ɛ sequences with similar intensity. This epitope could be mapped with linear peptides as this part of the structure is flexible without a constrained conformation (see Figure 2).
Pepscan linear epitope mapping can provide an in-depth view into the linear sequence motifs required for an antibody to bind to its target. Cross-binding to homologous sequences or identifying antibodies that can uniquely bind to specific species targets can also be assessed for a single antibody or a panel of antibodies due to the reusability of the arrays.